Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder

NCT03572933 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

CDKL5 Deficiency Disorder

Interventions

DRUG: ganaxolone
DRUG: Placebo

Sponsor

Marinus Pharmaceuticals